Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Sandoz
Sort By
Newest First
Sign in
1 / 1
1 / 1
Antibiotics
Sandoz Announces Plans for Joint Investment to Help Strengthen Future of Antibiotics Manufacturing in Europe
Sandoz
PR-M07-20-NI-38
Jul 27, 2020
M&A
Sandoz Announces Agreement to Acquire Aspen’s Japanese Operations
Sandoz
PR-M11-19-NI-009
Nov 13, 2019
FDA Approval
Sandoz Receives FDA Approval for Oncology Supportive Care Biosimilar Ziextenzo™
Sandoz
PR-M11-19-NI-006
Nov 08, 2019
Recall
FDA Announces Voluntary Recall of Sandoz Ranitidine Capsules Following Detection of an Impurity
U.S. Food & Drug Administration
PR-M09-19-NI-049
Sep 24, 2019
Recall
Sandoz Issues Voluntary Recall of Losartan
Nice Insight
PAO-M11-18-NI-016
Nov 20, 2018
FDA Approval
Sandoz Inc. Announces US FDA Approval of Pediatric Dose of SYMJEPI™ (Epinephrine)
Sandoz
PR-M10-18-NI-007
Oct 02, 2018
Annoucement
Novartis Unloads Sandoz US Components
Nice Insight
PAO-M09-18-NI-011
Sep 14, 2018
Licensing Agreement
DURECT Announces Amendment to Licensing Agreement with Sandoz Related to POSIMIR® (SABER®-Bupivacaine)
DURECT Corporation
PR-M05-18-NI-042
May 10, 2018
Acquisition
CASI Pharmaceuticals Acquires ANDA Portfolio From Sandoz Inc. (Sandoz)
CASI Pharmaceuticals, Inc.
PR-M02-18-NI-001
Feb 01, 2018
Biosimilars
Sandoz - Biocon Deal One More Sign That U.S. Biosimilars Have Arrived
Kalorama Information
PR-M01-18-NI-086
Jan 26, 2018
Regulatory
Sandoz regulatory submission for proposed biosimilar adalimumab accepted by FDA
Sandoz
PR-M01-18-NI-060
Jan 19, 2018
